SGHT Form 4: COO receives 23,006 RSUs vesting through 2029

Rhea-AI Filing Summary

Sight Sciences (SGHT) reported an insider equity grant. Chief Operating Officer Alison Bauerlein acquired 23,006 RSUs on November 11, 2025 under the company’s 2021 Incentive Award Plan at a stated price of $0 per unit. The award equals approximately $150,000 of common stock based on the grant-date price, with each RSU representing one share.

The RSUs vest in 16 equal quarterly installments from December 31, 2025 through September 30, 2029, contingent on continued service. Following this grant, Bauerlein beneficially owned 620,526 shares directly.

Insights

Equity compensation analyst

Routine Form 4: time-vested RSU grant with multi-year schedule.

The COO received 23,006 RSUs on November 11, 2025 under the 2021 plan, valued at approximately $150,000 using the grant-date stock price. RSUs convert one-for-one into common shares as they vest and have no expiration date.

Vesting occurs in 16 equal quarterly installments from December 31, 2025 through September 30, 2029, contingent on continued service. This structure spreads recognition over four years and staggers potential share delivery.

The filing shows total beneficial ownership of 620,526 shares after the grant. As a standard compensation award without immediate sale or exercise, market impact typically depends on future vesting and any subsequent dispositions.

Insider Trade Summary

Net Buyer: 23,006 shares

Net Buy 1 txn

Insider Bauerlein Alison

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	23,006	$0.00	$0.00

Holdings After Transaction: Common Stock — 620,526 shares (Direct)

Footnotes (1)

1. F1. Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing December 31, 2025 and continuing through September 30, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $150,000 of shares of Common Stock as determined by the stock price on the grant date, November 11, 2025. The RSUs have no expiration date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/13/2025 - 04:35 PM Learn about SEC filing dates

FAQ

What did SGHT report on Form 4?

A grant of 23,006 RSUs to COO Alison Bauerlein on November 11, 2025 under the 2021 Incentive Award Plan.

How do the RSUs for SGHT's COO vest?

They vest in 16 equal quarterly installments from December 31, 2025 through September 30, 2029, subject to continued service.

What is the value of the RSU grant reported by SGHT?

Approximately $150,000, determined by the stock price on the November 11, 2025 grant date.

What does each RSU represent in the SGHT grant?

Each RSU represents a contingent right to receive one share of SGHT common stock.

What is the reporting person’s ownership after the SGHT grant?

Beneficial ownership is listed as 620,526 shares following the reported transaction.

Does the SGHT RSU award have an expiration date?

No. The filing states the RSUs have no expiration date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bauerlein Alison

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/11/2025		A		23,006(1)	A	$0	620,526	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing December 31, 2025 and continuing through September 30, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $150,000 of shares of Common Stock as determined by the stock price on the grant date, November 11, 2025. The RSUs have no expiration date.

	/s/Jeremy Hayden, Attorney-in-Fact for Alison Bauerlein	11/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.